Cover Image
市場調查報告書

美國的大主動脈內氣球幫浦 市場分析

US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore

出版商 iData Research Inc. 商品編碼 590199
出版日期 內容資訊 英文 392 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的大主動脈內氣球幫浦 市場分析 US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore
出版日期: 2017年11月01日 內容資訊: 英文 392 Pages
簡介

本報告提供美國國內的大主動脈內氣球幫浦 市場相關分析,彙整整體市場結構和近來主要的事件關聯性,市場規模的轉變及預測 (過去4年·今後7年份),推動及阻礙市場要素,近幾年的企業間競爭·資本交易情勢,主要企業的簡介等資訊,為您概述為以下內容。

摘要整理

美國的心血管手術·心臟瓣膜設備市場概要

競爭分析

市場趨勢

市場發展

治療數量

分析對象的治療編碼

分析對象市場

主要報告的更新情形

過去的版本

分析方法

  • 分析範圍
  • IDATA的9級分析方法

疾病概要

  • 人體結構
    • 冠狀動脈疾病
    • 心肌梗塞
    • 心絞痛
    • 心臟瓣膜症
    • 充血性心臟衰竭

產品系列

  • 簡介
    • 組織心臟瓣膜
    • 機器心臟瓣膜
    • 瓣環成形術 (修復) 設備
    • 經導管二尖瓣瓣膜修復術
    • 經導管置換心瓣膜手術術
    • 體外循環輔助下冠狀動脈繞道手術 (ONCAB) 設備
    • 非體外循環冠狀動脈繞道手術 (OPCAB) 設備
    • EVH (內視鏡取血管手術) 設備
    • 吻合補助設備
    • 經心肌血液循環重組設備
    • 心室補助設備
    • 大主動脈內氣球幫浦 設備
    • 人工心臟設備
    • 血液循環動態遠程監控系統
    • 心房中隔缺損 (ASD)/心室中隔缺損 (VSD) 設備
    • 左心耳封閉設備
    • EMOM (體外式薄膜型人工肺)
  • FDA (美國食品藥物管理局) 的回收
    • MAQUET
    • Medtronic
    • HeartWare Inc
  • 臨床實驗趨勢
    • Medtronic
    • St. Jude Medical
    • Abiomed
    • Heartware Inc

大主動脈內氣球幫浦 的市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 拋棄式用品的市場
      • 傳統主動脈內球囊導管
      • 光纖製球囊導管
    • 大主動脈內氣球幫浦 操作設備的市場
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 各企業市場佔有率分析

簡稱一覽

附錄·各企業的新聞稿一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USCS18_MC_IABP

Counterpulsation therapy is used during surgery to provide temporary assistance to the heart. Counterpulsation refers to the inflation and deflation of an intra-aortic balloon synchronized with the heartbeat. The therapy increases the heart's output and the supply of oxygen-rich blood to the heart's coronary arteries while reducing the heart muscle's workload and its oxygen demand. Counterpulsation is performed using intra-aortic balloon pump (IABP) devices.

An intra-aortic balloon pump system is used for the treatment of high-risk cardiac conditions resulting from ischemic heart disease and heart failure. Patients experiencing acute coronary syndromes such as acute myocardial infarction (AMI), cardiogenic shock and unstable angina may require IABP therapy to support and stabilize their cardiac status. The therapy may also be used for high-risk patients who require revascularization procedures, such as percutaneous coronary interventions (PCI) or coronary artery bypass grafting (CABG) procedures, including both on-pump and off-pump CABG procedures. IABP products and therapy may be used before or during CABG or PCI interventions for hemodynamic support.

The IABP market comprises capital equipment pump console units and disposable intra-aortic balloon catheters that serve as the pumping device within the patient's aorta. Datascope, now acquired by Maquet, introduced the first balloon catheter capable of percutaneous insertion. This innovation eliminated the restricted use of IABPs to surgical insertion during CABG procedures and allowed for the expansion of IABPs into the realm of interventional cardiology.

TABLE OF CONTENTS I

LIST OF FIGURES XII

LIST OF CHARTS XV

EXECUTIVE SUMMARY 1

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 7

MARKET DEVELOPMENTS 11

PROCEDURE NUMBERS 12

PROCEDURE CODES INVESTIGATED 16

MARKETS INCLUDED 17

KEY REPORT UPDATES 19

VERSION HISTORY 20

RESEARCH METHODOLOGY 21

    • Step 1: Project Initiation & Team Selection 21
    • Step 2: Prepare Data Systems and Perform Secondary Research 24
    • Step 3: Preparation for Interviews & Questionnaire Design 26
    • Step 4: Performing Primary Research 27
    • Step 5: Research Analysis: Establishing Baseline Estimates 29
    • Step 6: Market Forecasts and Analysis 30
    • Step 7: Identify Strategic Opportunities 32
    • Step 8: Final Review and Market Release 33
    • Step 9: Customer Feedback and Market Monitoring 34

DISEASE OVERVIEW 35

  • 2.1 BASIC ANATOMY 35
    • 2.1.11 Coronary Artery Disease 37
    • 2.1.12 Myocardial Infarction 37
    • 2.1.13 Angina Pectoris 38
    • 2.1.14 Heart Valve Disease 39
    • 2.1.15 Congestive Heart Failure 39

PRODUCT PORTFOLIO 41

    • 3.1.1 Tissue Heart Valves 41
    • 3.1.2 Mechanical Tissue Heart Valves 43
    • 3.1.3 Annuloplasty Repair Devices 45
    • 3.1.4 Transcatheter Aortic Valve Replacement Devices 47
    • 3.1.5 Transcatheter Mitral Valve Repair Devices 49
    • 3.1.6 On-Pump Coronary Artery Bypass Devices 50
    • 3.1.7 Off-Pump Coronary Artery Bypass Devices 52
    • 3.1.8 Endoscopic Vessel Harvesting Devices 53
    • 3.1.9 Anastomosis Assist Devices 54
    • 3.1.10 Transmyocardial Revascularization Devices 55
    • 3.1.11 Ventricular Assist Devices 56
    • 3.1.12 Intra-Aortic Balloon Pump Device 57
    • 3.1.13 Temporary Artificial Heart Replacement Device 58
    • 3.1.14 Remote Hemodynamic Monitoring System Devices 59
    • 3.1.15 Patent Foramen Ovale Devices 59
    • 3.1.16 Atrial & Ventricular Septal Defect Device 61
    • 3.1.17 Left Atrial Appendage Closure Device 62
    • 3.1.18 Extracorporeal Membrane Oxygenation Machine 63
  • 3.2 FDA RECALLS 64
    • 3.2.1 MAQUET 64
    • 3.2.2 Medtronic 66
    • 3.2.3 HeartWare Inc 67
  • 3.3 CLINICAL TRIALS 68
    • 3.3.1 Medtronic 68
    • 3.3.2 St. Jude Medical 70
    • 3.3.3 Abiomed 75
    • 3.3.4 Heartware Inc 76

INTRA-AORTIC BALLOON PUMP MARKET 78

  • 4.1 INTRODUCTION 78
  • 4.2 MARKET OVERVIEW 79
  • 4.3 MARKET ANALYSIS AND FORECAST 82
    • 4.3.1 Intra-Aortic Balloon Pump Disposables Market 82
      • 4.3.1.1 Conventional Intra-Aortic Balloon Catheter Market 88
      • 4.3.1.2 Fiber Optic Intra-Aortic Balloon Catheter Market 90
    • 4.3.2 Intra-Aortic Balloon Pump Console Market 92
  • 4.4 DRIVERS AND LIMITERS 94
    • 4.4.1 Market Drivers 94
    • 4.4.2 Market Limiters 95
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS 97

ABBREVIATIONS 100

APPENDIX: COMPANY PRESS RELEASES 103

LIST OF CHARTS

  • Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 - 2024 3
  • Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024 3
  • Chart 4 1: Intra-Aortic Balloon Pump Market by Segment, U.S., 2014 - 2024 80
  • Chart 4 2: Intra-Aortic Balloon Pump Market Breakdown by Segment, U.S., 2017 81
  • Chart 4 3: Intra-Aortic Balloon Pump Market Breakdown by Segment, U.S., 2024 81
  • Chart 4 4: Intra-Aortic Balloon Pump Disposables Market by Segment, U.S., 2014 - 2024 84
  • Chart 4 5: Intra-Aortic Balloon Pump Disposables Market Breakdown by Segment, U.S., 2017 85
  • Chart 4 6: Intra-Aortic Balloon Pump Disposables Market Breakdown by Segment, U.S., 2024 85
  • Chart 4 7: Intra-Aortic Balloon Pump Disposables Market, U.S., 2014 - 2024 87
  • Chart 4 8: Conventional Intra-Aortic Balloon Catheter Market, U.S., 2014 - 2024 89
  • Chart 4 9: Fiber Optic Intra-Aortic Balloon Catheter Market, U.S., 2014 - 2024 91
  • Chart 4 10: Intra-Aortic Balloon Pump Console Market, U.S., 2014 - 2024 93
  • Chart 4 11: Leading Competitors, Intra-Aortic Balloon Pump Market, U.S., 2017 99

LIST OF FIGURES

  • Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4) 4
  • Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4) 5
  • Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4) 5
  • Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4) 5
  • Figure 1 5: Companies Researched in this Report, U.S., 2017 6
  • Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4) 7
  • Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4) 8
  • Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4) 9
  • Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4) 10
  • Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 - 2017 11
  • Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4) 12
  • Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4) 13
  • Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4) 14
  • Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4) 15
  • Figure 1 15: Procedure Codes Investigated, U.S., 2017 16
  • Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2) 17
  • Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2) 18
  • Figure 1 18: Key Report Updates (1 of 2) 19
  • Figure 1 19: Key Report Updates (2 of 2) 20
  • Figure 1 20: Version History 20
  • Figure 3 1: Tissue Heart Valves by Company 42
  • Figure 3 2: Mechanical Tissue Heart Valves by Company 44
  • Figure 3 3: Annuloplasty Repair Devices by Company 46
  • Figure 3 4: Transcatheter Heart Valve Replacement Devices by Company 48
  • Figure 3 5: Transcatheter Mitral Valve Repair Devices by Company 49
  • Figure 3 6: On-Pump Coronary Artery Bypass Devices by Company 51
  • Figure 3 7: Off-Pump Coronary Artery Bypass Devices by Company 52
  • Figure 3 8: Endoscopic Vessel Harvesting Devices by Company 53
  • Figure 3 9: Anastomosis Assist Devices by Company 54
  • Figure 3 10: Transmyocardial Revascularization Devices by Company 55
  • Figure 3 11: Ventricular Assist Devices by Company 56
  • Figure 3 12: Intra-Aortic Balloon Devices by Company 57
  • Figure 3 13: Temporary Artificial Heart Replacement Devices by Company 58
  • Figure 3 14: Remote Hemodynamic Monitoring System Devices by Company 59
  • Figure 3 15: Patent Foramen Ovale Devices by Company 60
  • Figure 3 16: Atrial & Ventricular Septal Defect Devices by Company 61
  • Figure 3 17: Left Atrial Appendage Closure Devices by Company 62
  • Figure 3 18: Extracorporeal Membrane Oxygenation Machine by Company 63
  • Figure 3 19: Class 2 Device Recall MAQUET 64
  • Figure 3 20: Class 2 Device Recall MAQUET 64
  • Figure 3 21: Class 2 Device Recall MAQUET 65
  • Figure 3 22: Class 1 Device Recall Medtronic 66
  • Figure 3 23: Class 1 Device Recall Heartware Inc 67
  • Figure 3 24: The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study 68
  • Figure 3 25: Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance 68
  • Figure 3 26: Medtronic CoreValve Evolut R U.S. Clinical Study 69
  • Figure 3 27: Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients 69
  • Figure 3 28: AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption 70
  • Figure 3 29: AMPLATZER Duct Occluder II Additional Sizes (ADO II AS) 70
  • Figure 3 30: HeartMate 3 CE Mark Study Long Term Follow-up (HM3 CE LTFU) 71
  • Figure 3 31: Trifecta™ GT Post Market Clinical Follow-up 71
  • Figure 3 32: AMPLATZER™ LAA Occluder Post Approval Study (PAS) 72
  • Figure 3 33: AMPLATZER™ Cardiac Plug Observational Post-Approval Study (ACP PAS China) 72
  • Figure 3 34: MOMENTUM 3 Continued Access Protocol (MOMENTUM 3 CAP) 73
  • Figure 3 35: AMPLATZER™ Amulet™ LAA Occluder Trial (Amulet IDE) 73
  • Figure 3 36: Prevention of Non-Surgical Bleeding by Management of HeartMate II 74
  • Figure 3 37: Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction (DTU) 75
  • Figure 3 38: Protected PCI Study 75
  • Figure 3 39: Assessment of the WATCHMAN™ Device 76
  • Figure 3 40: Watchman FLX Left Atrial Appendage Closure Device Post Approval Study 76
  • Figure 3 41: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology 77
  • Figure 4 1: Intra-Aortic Balloon Pump Market by Segment, U.S., 2014 - 2024 (US$M) 79
  • Figure 4 2: Intra-Aortic Balloon Pump Disposables Market by Segment, U.S., 2014 - 2024 (US$M) 83
  • Figure 4 3: Intra-Aortic Balloon Pump Disposables Market, U.S., 2014 - 2024 86
  • Figure 4 4: Conventional Intra-Aortic Balloon Catheter Market, U.S., 2014 - 2024 88
  • Figure 4 5: Fiber Optic Intra-Aortic Balloon Catheter Market, U.S., 2014 - 2024 90
  • Figure 4 6: Intra-Aortic Balloon Pump Console Market, U.S., 2014 - 2024 92
  • Figure 4 7: Drivers and Limiters, Intra-Aortic Balloon Pump Market, U.S., 2017 96
  • Figure 4 8: Leading Competitors, Intra-Aortic Balloon Pump Market, U.S., 2017 98
  • Figure 6 1: Press Release Summary 103
Back to Top